Tag: M.W=150-200

Recommanded Product: 2,4-Dichlorobenzoic acid. Authors Anastassiadou, M; Bernasconi, G; Brancato, A; Cabrera, LC; Ferreira, L; Greco, L; Jarrah, S; Kazocina, A; Leuschner, R; Magrans, JO; Miron, I; Nave, S; Pedersen, R; Reich, H; Rojas, A; Sacchi, A; Santos, M; Scarlato, AP; Theobald, A; Vagenende, B; Verani, A in EUROPEAN FOOD SAFETY AUTHORITY-EFSA published article about in [Anastassiadou, Maria; Bernasconi, Giovanni; Brancato, Alba; Cabrera, Luis Carrasco; Ferreira, Lucien; Greco, Luna; Jarrah, Samira; Kazocina, Aija; Leuschner, Renata; Magrans, Jose Oriol; Miron, Ileana; Nave, Stefanie; Pedersen, Ragnor; Reich, Hermine; Rojas, Alejandro; Sacchi, Angela; Santos, Miguel; Scarlato, Alessia Pia; Theobald, Anne; Vagenende, Benedicte; Verani, Alessia] European Food Safety Author EFSA, Parma, Italy in 2021, Cited 4. The Name is 2,4-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-84-0

The applicant Syngenta Crop Protection AG submitted a request to the competent national authority in Finland to evaluate the confirmatory data that were identified for propiconazole in the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005 as not available. Following the decision on the non-renewal of the approval of propiconazole and the decision to lower the maximum residue levels (MRLs) for propiconazole to the limit of quantification (LOQ) for all commodities, the data gaps identified in the MRL review are no longer relevant. EFSA summarised some new studies on the toxicological profile of propiconazole metabolites CGA91305, SYN547889 and NOA436613, which were assessed by the rapporteur Member State. Overall, the available information is not sufficient to characterise the toxicological profile of metabolites convertible to 2,4-dichlorobenzoic acid as data gaps still exist for SYN547889, NOA436613, CGA118244, CGA118245, CGA91304 and CGA91305. (C) 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.

Recommanded Product: 2,4-Dichlorobenzoic acid. Bye, fridends, I hope you can learn more about C7H4Cl2O2, If you have any questions, you can browse other blog as well. See you lster.

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics

Recently I am researching about NIPECOTIC ACID-DERIVATIVES; ANTIEPILEPTIC DRUGS; DESIGN; MODEL; 1,3,4-OXADIAZOLE; TRANSPORTER; MECHANISMS; EPILEPSY, Saw an article supported by the . Name: 2,4-Dichlorobenzoic acid. Published in ELSEVIER in AMSTERDAM ,Authors: Singh, RB; Das, N; Singh, GK; Singh, SK; Zaman, K. The CAS is 50-84-0. Through research, I have a further understanding and discovery of 2,4-Dichlorobenzoic acid

In the present study, we have synthesized a series of fifteen nipecotic acid 1,3,4-oxadiazole based hybrids with significant (60-78%) yields. All the compounds were characterized by using different spectroanalytical techniques such as FT-IR, H-1 NMR, C-13 NMR, and elemental analysis. This design strategy was validated by using in vivo anti-epileptic and anti-depressant bioassay models. Anti-convulsant activity was evaluated using subcutaneous pentylenetetrazol (scPTZ) in mice and MES induced seizure. Among a spectrum of activities, three compounds (4i, 4m, and 4n) displayed significant activity against pentylenetetrazole (scPTZ) induced seizures. No disruptions in motor co-ordination were observed in mice pretreated with the test compounds in the rotarod test. Their influence on the safety profile of elevated serum levels of biochemical markers such as hepatic and renal toxicity has been found to be safe. The derivatives also show marked anti-depressant activity, devoid of serotonergic augmentation as assessed using the despair swim test, 5-hydroxytryptophan (5-HTP)-induced head twitch test and learned helplessness test. In silico docking studies targeted on homology modelled GABA transporter 1 (GAT1) protein shows the critical enzyme-ligand interactions leading to the inhibition of the GAT1 transporter. The compound 4m was found to be the most active compound among all the synthesized compounds. (C) 2020 Published by Elsevier B.V. on behalf of King Saud University.

Name: 2,4-Dichlorobenzoic acid. Bye, fridends, I hope you can learn more about C7H4Cl2O2, If you have any questions, you can browse other blog as well. See you lster.

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics

Tian, K; Li, XQ; Zhang, L; Gan, YY; Meng, J; Wu, SQ; Wan, JL; Xu, Y; Cai, CT; Ouyang, GP; Wang, ZC in [Tian, Kun; Li, Xiao-Qin; Zhang, Li; Wu, Shou-Qun; Wan, Jin-Lin; Ouyang, Gui-Ping] Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ,Ctr Res & Dev Fine Chem, Guiyang 550025, Guizhou, Peoples R China; [Gan, Yi-Yuan; Meng, Jiao; Xu, Yang; Cai, Chao-Ting; Ouyang, Gui-Ping; Wang, Zhen-Chao] Guizhou Univ, Coll Pharm, Guiyang 550025, Guizhou, Peoples R China; [Ouyang, Gui-Ping; Wang, Zhen-Chao] Drug Synthet Engn Lab Guizhou Prov, Guiyang 550025, Guizhou, Peoples R China published Synthesis of novel indole derivatives containing double 1,3,4-oxadiazole moiety as efficient bactericides against phytopathogenic bacterium Xanthomonas oryzae in 2019, Cited 37. Formula: C7H4Cl2O2. The Name is 2,4-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-84-0.

A series of novel indole derivatives containing double 1,3,4-oxadiazole moiety was designed, synthesized and evaluated for their antibacterial activities in vitro. These compounds were fully characterized by H-1 NMR, C-13 NMR, and HRMS. Bioassay results indicated that most of title compounds exhibited excellent antibacterial activities against rice bacterial pathogen Xanthomonas oryzae (Xoo). For example, compounds 7d, 7h, 7i, 7j, 7k, 7l and 7m had the half-maximal effective concentration (EC50) values of 52.31, 54.12, 40.65, 38.80, 51.13, 52.75 and 50.66 mu g/mL, respectively, which was better than that of commercial product bismerthiazol (BMT) (85.18 mu g/mL). The experimental results proved that indole derivatives bearing double 1,3,4-oxadiazole unit are promising candidates for the development of new agricultural bactericides against pathogenic bacterium Xoo. [GRAPHICS] .

Welcome to talk about 50-84-0, If you have any questions, you can contact Tian, K; Li, XQ; Zhang, L; Gan, YY; Meng, J; Wu, SQ; Wan, JL; Xu, Y; Cai, CT; Ouyang, GP; Wang, ZC or send Email.. Formula: C7H4Cl2O2

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics

Bagal, SK; Omoto, K; Blakemore, DC; Bungay, PJ; Bilsland, JG; Clarke, PJ; Corbett, MS; Cronin, CN; Cui, JJ; Dias, R; Flanagan, NJ; Greasley, SE; Grimley, R; Johnson, E; Fengas, D; Kitching, L; Kraus, ML; McAlpine, I; Nagata, A; Waldron, GJ; Warmus, JS in [Bagal, Sharan K.; Omoto, Kiyoyuki; Blakemore, David C.] Pfizer Global R&D UK, Worldwide Med Chem, Portway Bldg,Granta Pk, Cambridge CB21 6GS, England; [Bungay, Peter J.] Pfizer Global R&D UK, Pharmacokinet Dynam & Metab, Portway Bldg,Granta Pk, Cambridge CB21 6GS, England; [Bilsland, James G.; Dias, Rebecca; Flanagan, Neil J.; Grimley, Rachel; Kitching, Linda; Waldron, Gareth J.] Pfizer Global R&D UK, Portway Bldg,Granta Pk, Cambridge CB21 6GS, England; [Corbett, Matthew S.; Warmus, Joseph S.] Pfizer Global R&D, Groton Labs, Eastern Point Rd, Groton, CT 06340 USA; [Cronin, Ciaran N.; Cui, J. Jean; Greasley, Samantha E.; Johnson, Eric; Kraus, Michelle L.; McAlpine, Indrawan; Nagata, Asako] Pfizer Global R&D, La Jolla Labs, 10770 Sci Ctr Dr, San Diego, CA 92121 USA; [Clarke, Philip J.; Fengas, David] Peakdale Mol, Discovery Pk House,Ramsgate Rd, Sandwich CT13 9ND, Kent, England published Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors in 2019, Cited 61. Recommanded Product: 2,4-Dichlorobenzoic acid. The Name is 2,4-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-84-0.

Tropomyosin receptor kinases (TrkA, TrkB, TrkC) are activated by hormones of the neurotrophin family: nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3), and neurotrophin 4 (NT4). Moreover, the NGF antibody tanezumab has provided clinical proof of concept for inhibition of the TrkA kinase pathway in pain leading to significant interest in the development of small molecule inhibitors of TrkA. However, achieving TrkA subtype selectivity over TrkB and TrkC via a Type I and Type II inhibitor binding mode has proven challenging and Type III or Type IV allosteric inhibitors may present a more promising selectivity design approach. Furthermore, TrkA inhibitors with minimal brain availability are required to deliver an appropriate safety profile. Herein, we describe the discovery of a highly potent, subtype selective, peripherally restricted, efficacious, and well-tolerated series of allosteric TrkA inhibitors that culminated in the delivery of candidate quality compound 23.

Recommanded Product: 2,4-Dichlorobenzoic acid. Welcome to talk about 50-84-0, If you have any questions, you can contact Bagal, SK; Omoto, K; Blakemore, DC; Bungay, PJ; Bilsland, JG; Clarke, PJ; Corbett, MS; Cronin, CN; Cui, JJ; Dias, R; Flanagan, NJ; Greasley, SE; Grimley, R; Johnson, E; Fengas, D; Kitching, L; Kraus, ML; McAlpine, I; Nagata, A; Waldron, GJ; Warmus, JS or send Email.

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics

Authors Verma, G; Khan, MF; Nainwal, LM; Ishaq, M; Akhter, M; Bakht, A; Anwer, T; Afrin, F; Islamuddin, M; Husain, I; Alam, MM; Shaquiquzzaman, M in ACADEMIC PRESS INC ELSEVIER SCIENCE published article about BIOLOGICAL EVALUATION; DERIVATIVES; ANTIMALARIAL; OXADIAZOLE; PYRAZOLE; DESIGN in [Verma, Garima; Khan, Mohemmed Faraz; Nainwal, Lalit Mohan; Akhter, Mymoona; Alam, Mohammad Mumtaz; Shaquiquzzaman, Mohammad] Jamia Hamdard, Dept Pharmaceut Chem, Sch Pharmaceut Educ & Res, New Delhi 110062, India; [Ishaq, Mohd] Jamia Hamdard, Dept Pharmacol, Sch Pharmaceut Educ & Res, New Delhi 110062, India; [Bakht, Afroz] Prince Sattam Bin Abdulassiss Univ, Coll Sci & Humanities, Dept Chem, POB 173, Al Kharj, Saudi Arabia; [Anwer, Tariq] Jassan Univ, Coll Pharm, Dept Pharmacol, POB 114, Gizan, Saudi Arabia; [Afrin, Farhat] Taibah Univ, Fac Appl Med Sci, Dept Med Lab Technol, Madina, Saudi Arabia; [Islamuddin, Mohammad; Husain, Ibraheem] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, Mol Virol Lab, New Delhi, India in 2019.0, Cited 27.0. Formula: C7H4Cl2O2. The Name is 2,6-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-30-6

In continuance with earlier reported work, an extension has been carried out by the same research group. Mulling over the ongoing condition of resistance to existing antimalarial agents, we had reported synthesis and antimalarial activity of certain pyrazole-1,3,4-oxadiazole hybrid compounds. Bearing previous results in mind, our research group ideated to design and synthesize some more derivatives with varied substitutions of acetophenone and hydrazide. Following this, derivatives 5a-r were synthesized and tested for antimalarial efficacy by schizont maturation inhibition assay. Further, depending on the literature support and results of our previous series, certain potent compounds (5f, 5n and 5r) were subjected to Falcipain-2 inhibitory assay. Results obtained for these particular compounds further strengthened our hypothesis. Here, in this series, compound 5f having unsubstituted acetophenone part and a furan moiety linked to oxadiazole ring emerged as the most potent compound and results were found to be comparable to that of the most potent compound (indole bearing) of previous series. Additionally, depending on the available literature, compounds (5a-r) were tested for their antileishmanial potential. Compounds 5a, 5c and 5r demonstrated dose-dependent killing of the promastigotes. Their IC50 values were found to be 33.3 +/- 1.68, 40.1 +/- 1.0 and 19.0 +/- 1.47 mu g/mL respectively. These compounds (5a, 5c and 5r) also had effects on amastigote infectivity with IC50 of 44.2 +/- 2.72, 66.8 +/- 2.05 and 73.1 +/- 1.69 mu g/mL respectively. Further target validation was done using molecular docking studies. Acute oral toxicity studies for most active compounds were also performed.

Formula: C7H4Cl2O2. Welcome to talk about 50-30-6, If you have any questions, you can contact Verma, G; Khan, MF; Nainwal, LM; Ishaq, M; Akhter, M; Bakht, A; Anwer, T; Afrin, F; Islamuddin, M; Husain, I; Alam, MM; Shaquiquzzaman, M or send Email.

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics

An article Concise Synthesis of Isocoumarins through Rh-Catalyzed Direct Vinylene Annulation: Scope and Mechanistic Insight WOS:000551552600081 published article about C-H/O-H; (ELECTRON-DEFICIENT ETA(5)-CYCLOPENTADIENYL)RHODIUM(III) CATALYST; BENZOIC-ACIDS; CARBOXYLIC-ACIDS; OXIDATIVE ANNULATION; NATURAL-PRODUCTS; ACTIVATION/ALKYNE ANNULATION; WEAK COORDINATION; ALPHA-PYRONES; N BOND in [Mihara, Gen; Ghosh, Koushik; Miura, Masahiro] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Nishii, Yuji] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka 5650871, Japan in 2020, Cited 66. The Name is 2,4-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-84-0. SDS of cas: 50-84-0

Transition-metal-catalyzed activation of inert C-H bonds and subsequent C-C bond formation have emerged as powerful synthetic tools for the synthesis of elaborate cyclic molecules. In this report, we introduce an efficient synthetic method of 3,4-unsubstituted isocoumarins adopting an electron-deficient (CpRh)-Rh-E complex as the catalyst. The use of vinylene carbonate as a vinylene transfer reagent enables the direct construction of isocoumarins from readily available benzoic acids, without any external oxidants as well as bases. The reaction mechanism is evaluated by computational analysis to find an unprecedented rhodium shift event within the catalytic cycle.

SDS of cas: 50-84-0. Welcome to talk about 50-84-0, If you have any questions, you can contact Mihara, G; Ghosh, K; Nishii, Y; Miura, M or send Email.

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics

An article Oxidative C-H Acyloxylation of Acetone with Carboxylic Acids under Iodine Catalysis WOS:000607120600001 published article about METHYL KETONES; INTRAMOLECULAR CYCLIZATION; ELECTROPHILIC CYCLIZATION; MICHAEL ADDITION; ACCESS; STRATEGY; ANILINES; HYDROCHLORIDE; DERIVATIVES; INDOLES in [Zhou, Xiao-Yu; Chen, Xia] Liupanshui Normal Univ, Sch Chem & Mat Engn, Liupanshui 553004, Peoples R China in 2021.0, Cited 63.0. The Name is 2,6-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-30-6. Safety of 2,6-Dichlorobenzoic acid

Iodine-catalyzed oxidative C(sp(3))-H acyloxylation of acetone with carboxylic acids has been developed. The method employs iodide-as catalyst and sodium chlorite as oxidant. Substituted benzoic acids, naphthoic acids and heteroaromatic carboxylic acids can be used, and 2-oxopropyl carboxylates are obtained with good to excellent yields.

Welcome to talk about 50-30-6, If you have any questions, you can contact Zhou, XY; Chen, X or send Email.. Safety of 2,6-Dichlorobenzoic acid

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics

Product Details of 50-30-6. In 2019.0 NICOTINE TOB RES published article about NICOTINE DELIVERY-SYSTEMS; UNITED-STATES; SOCIAL-CLASS; HEALTH; DISEASE; ADULTS; TRENDS; INEQUALITIES; ESTIMATORS; AWARENESS in [Friedman, Abigail S.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, 60 Coll St,Rm 303, New Haven, CT 06520 USA; [Horn, Samantha J. L.] Northwestern Univ, Global Poverty Res Lab, Evanston, IL USA in 2019.0, Cited 38.0. The Name is 2,6-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-30-6.

Introduction Socioeconomic disparities have been established for conventional cigarette use, but not for electronic cigarettes. This study estimates socioeconomic gradients in exclusive use of conventional cigarettes, electronic cigarettes, and dual use (ie, use of both products) among adults in the United States. Methods Analyses consider nationally representative data on 25- to 54-year-old respondents to the 2014-2016 National Health Interview Surveys (N = 50306). Demographically adjusted seemingly unrelated regression models estimate how two socioeconomic status measures-respondent education and household income-relate to current exclusive use of conventional cigarettes, electronic cigarettes, and dual use. Results Conventional cigarette use exhibits negative education and income gradients, consistent with existing research: -12.9 percentage points (confidence interval [CI]: -14.0, -11.8) if college educated, and -9.5 percentage points (CI: -10.9, -8.1) if household income exceeds 400% of the federal poverty level. These gradients are flatter for dual use (-1.4 [CI: -1.8, -0.9] and -1.9 [CI: -2.5, -1.2]), and statistically insignificant for electronic cigarette use (-0.03 [CI: -0.5, 0.4] and -0.3 [CI: -0.8, -0.2]). Limiting the sample to ever-smokers, higher education is associated with a 0.9 percentage point increase in likelihood of exclusive electronic cigarette use at interview (CI: 0.0, 1.9). Conclusions Education and income gradients in exclusive electronic cigarette use are small and statistically insignificant, contrasting with strong negative gradients in exclusive conventional cigarette use. Furthermore, more educated smokers are more likely to switch to exclusive e-cigarette use than less educated smokers. Such differential switching may exacerbate socioeconomic disparities in smoking-related morbidity and mortality, but lower the burden of tobacco-related disease. Implications Research has not yet established whether socioeconomic disparities in electronic cigarette (e-cigarette) use resemble those observed for conventional cigarettes. This article uses nationally representative data on US adults aged 25-54 to estimate income and education gradients in exclusive use of conventional cigarettes, e-cigarettes, and dual use. Both gradients are steep and negative for conventional cigarette use, but flat and statistically insignificant for e-cigarette use. Repeating the analysis among ever-smokers indicates that more educated smokers are more likely to transition toward exclusive e-cigarette use than less educated smokers. Such differential substitution may exacerbate disparities in smoking-related morbidity and mortality.

Product Details of 50-30-6. Welcome to talk about 50-30-6, If you have any questions, you can contact Friedman, AS; Horn, SJL or send Email.

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics

An article Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA) WOS:000476715300029 published article about ANTIMICROBIAL ACTIVITY; 1,3,4-OXADIAZOLE; DERIVATIVES; QUINOLONES; DISCOVERY; ANALOGS in [Guo, Yong; Xu, Ting; Bao, Chongnan; Liu, Zhiyan; Fan, Jiangping; Yang, Ruige; Qin, Shangshang] Zhengzhou Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Adv Drug Preparat Technol, 100 KeXue Ave, Zhengzhou 450001, Henan, Peoples R China in 2019, Cited 27. The Name is 2,4-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-84-0. Safety of 2,4-Dichlorobenzoic acid

Toward the search of new antibacterial agents to control methicillin-resistant Staphylococcus aureus (MRSA), a class of new norfloxacin-1,3,4-oxadiazole hybrids were designed and synthesized. Antibacterial activities against drug-sensitive bacteria S. aureus and clinical drug resistant isolates of MRSA were evaluated. Compound 5k exhibited excellent antibacterial activities against S. aureus (MIC: 2 mu g/mL) and MRSA1-3 (MIC: 0.25-1 mu g/mL). The time-kill kinetics demonstrated that compound 5k had an advantage over commonly used antibiotics vancomycin in killing S. aureus and MRSA. Moreover, compound 5k could inhibit the bacteria and destroy their membranes in a short time, and showed very low cytotoxicity to NRK-52E cells. Some interesting structure-activity relationships (SARs) were also discussed. These results indicated that these norfloxacin-1,3,4-oxadiazole hybrids could be further developed into new antibacterial agents against MRSA.

Safety of 2,4-Dichlorobenzoic acid. About 2,4-Dichlorobenzoic acid, If you have any questions, you can contact Guo, Y; Xu, T; Bao, CN; Liu, ZY; Fan, JP; Yang, RG; Qin, SS or concate me.

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics

In 2020 EUR J MED CHEM published article about MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; CANCER; REVERSAL; MODULATORS; MECHANISMS; AGENTS; CELLS in [Wan, Qi; Guo, Yalan; Yu, Zhihui; Guo, Shiqi; Chen, Ying] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai, Peoples R China; [Jin, Xin; Liu, Hongrui] Fudan Univ, Sch Pharm, Dept Pharmacol & Biochem, Shanghai, Peoples R China; [Morris-Natschke, Susan; Lee, Kuo-Hsiung] Univ N Carolina, UNC Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung 40402, Taiwan in 2020, Cited 21. The Name is 2,4-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-84-0. HPLC of Formula: C7H4Cl2O2

Thirty-four seco-3’R,4’R-disubstituted-2′,2′-dimethyldihydropyrano[2,3-f]chromone (seco-DSP) derivatives were designed, synthesized and evaluated for chemo-reversal activity when combined with paclitaxel or vincristine in P-gp overexpressing A2780/T and KB-VIN drug-resistant cancer cell lines. Most of the compounds displayed moderate to significant MDR reversal activities. Compound 7e showed the most potent chemo-sensitization activity with more than 1471 reversal ratio at a concentration of 10 mu M, which was higher than verapamil (VRP) (212-fold). Unexpectedly the newly synthesized compounds did not show chemosensitization activities in a non-P-gp overexpressing cisplatin resistant human ovarian cancer cell line (A2780/CDDP), implying that the MDR reversal effects might be associated with P-gp overexpression. Moreover, the compounds did not exhibit significant anti-proliferative activities against non-tumorigenic cell lines (HUVEC, HOSEC and T29) compared to VRP at the tested concentration and might be safer than VRP. In preliminary pharmacological mechanism studies, the compounds increased accumulation of DOX and promoted P-gp ATPase activity in A2780/T cell lines. Western blot analysis indicated they did not affect the expression level of P-gp in the tested MDR cell lines. Thus, further studies on these seco-DSP derivatives are merited with the goal of developing a desirable chemosensitizer drug candidate. (C) 2020 Elsevier Masson SAS. All rights reserved.

About 2,4-Dichlorobenzoic acid, If you have any questions, you can contact Wan, Q; Jin, X; Guo, YL; Yu, ZH; Guo, SQ; Morris-Natschke, S; Lee, KH; Liu, HR; Chen, Y or concate me.. HPLC of Formula: C7H4Cl2O2

Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics